MEREDITH SPEIGHT: Open Payments
NPI 1679298590 · HENDERSON, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,177 in 75 payments from 18 companies in 2025. Trend: 2023 $0 · 2024 $822 · 2025 $2,177
Food & beverage: $1,831Education: $302Consulting: $44
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 15 | $340 |
| Regeneron Healthcare Solutions, Inc. | 14 | $336 |
| ARS Pharmaceuticals Operations, Inc. | 4 | $298 |
| AstraZeneca Pharmaceuticals LP | 9 | $261 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $168 |
| GENZYME CORPORATION | 8 | $168 |
| Lilly USA, LLC | 1 | $122 |
| Novartis Pharmaceuticals Corporation | 5 | $120 |
| SANOFI-AVENTIS U.S. LLC | 1 | $88 |
| Grifols USA, LLC | 2 | $53 |
Products named: DUPIXENT, NUCALA, NEFFY, AIRSUPRA, EBGLYSS, FASENRA, EOHILIA, TAKHZYRO.
Industry payments across NV — which companies pay providers there.
